Politics Rachel Cohrs Zhang STAT Plus: Judge tosses PhRMA lawsuit over Medicare power to negotiate drug prices
Exclusive Helen Branswell STAT Plus: HHS leaves vacant more than half the slots on a key vaccine advisory panel
Politics Rachel Cohrs Zhang STAT Plus: The lone Democrat willing to weaken Medicare’s power to negotiate drug prices
Politics John Wilkerson STAT Plus: Judge skeptical of arguments against Medicare drug price negotiation
Politics Sarah Owermohle STAT Plus: FDA’s Woodcock reflects on more than 30 years at agency — and hints at what’s next
Politics Sarah Owermohle Can the government ask social media sites to take down Covid misinformation? SCOTUS will weigh in
The Readout Damian Garde STAT Plus: Ahead of Medicare drug price reform, pharma’s drug pricing has a Streisand effect
Politics John Wilkerson STAT Plus: Pharma’s attack on Medicare drug price negotiation might benefit Biden
Politics Brittany Trang STAT Plus: The White House has a pharmacy — and it was a mess, a new investigation found
Exclusive Rachel Cohrs Zhang STAT Plus: Congress’ negotiations over doc pay, health centers fell apart ahead of spending extension
Insurance Brittany Trang STAT Plus: Biden changes will force health insurers to speed up and get more specific if they want to deny care
Politics John Wilkerson STAT Plus: Copay coupons for some drugs must count toward deductibles, after Biden court move
Politics Sarah Owermohle STAT Plus: The new NIH director is walking a tightrope on Biden’s drug pricing vision
Business Brittany Trang STAT Plus: Could private equity be the future of private practice? A new lobbying group thinks so